Life Sciences Archivi - Pagina 14 di 16

22 maggio 2023

Vascular Patches Industry Development, Demand and Forecast Report 2030

The vascular patches market had the revenue of USD 387.3 million in 2022, which will power at a CAGR of 8.1% in the years to come, to touch a value of USD 724.2 million by 2030.

The main risk for patients now is multi-morbidity, denoting the concurrent occurrence of two or more chronic ailments. Approximately 80% of the adults aged 65 and above have two or more chronic ailments, and 68% have three or more.

The biological category had a larger share of revenue, about 60%, in 2022, and it will maintain its dominance in the years to come. This is because biological variants are extensively used for closing the arteries during cardiac surgeries.

These patches have more than a few advantages over their synthetic counterparts, such as advanced compatibility with the living tissue, less toxic, lesser risk of immunological refusals, and ease of usage. They also minimalize suture line bleeding and decrease the probabilities of infection.

The CEA category had the largest share, about 40% in the past, because of the increase in the number of these surgeries. A methodical review of randomized clinical trials found that patch angioplasty in conventional CEA could decrease the risk of a recurring restenosis and ipsilateral stroke, associated to a main closure.

Also, vascular bypass surgery will observe a considerable growth in the years to come as a result of the accessibility of reimbursement in developing and developed economies.

North American vascular patches market dominated with about 40% share, in 2022 as per a report by P&S Intelligence, a market research institution. This has a lot to do with the constant growth in healthcare technologies, fast changing lifestyles, increasing incidence of cardiac ailments and hernia, growing consumption of tobacco and alcohol, rising obesity levels, and increasing substance abuse.

Furthermore, the increasing frequency of product introductions and the commercialization of state-of-the-art treatments power advance of the industry. The region also dominates the market because of the progressions in its healthcare infra and a beneficial insurance compensation situation for vascular treatments.

Furthermore, Europe follows North America due to the presence of prominent research organizations and market players, and the favorable regulations of governments that inspire surgeries for the predictive management of ailments.

Also, Germany is showing momentous growth. This is because of the increase in its healthcare budget, acceptance of cutting-edge technologies, promising reimbursement policy for vascular procedures, and robust preference for surgeries amongst healthcare staffs for CHDs.

It is because of the increasing prevalence of vascular disorders, the demand for vascular patches is increasing, and will increase considerably by the end of this decade.

18 maggio 2023

Veterinary Pain Management Industry Will Reach $2.78 Billion By 2030

In 2022, the veterinary pain management market was worth around USD 1.60 billion, and it is projected to advance at a 7.10% CAGR from 2022 to 2030, hitting USD 2.78 billion by 2030, according to P&S Intelligence.

This development can be credited to the growing occurrence of musculoskeletal syndromes, including osteoarthritis, in animals, also the increasing acceptance of buddy and livestock animals. Furthermore, the developments in the animal healthcare industry have led to the increasing requirement for veterinary pain management items.

In 2022, the drug category led the product segment, with a veterinary pain management market share of above 88%, credited to the growing utilization of nonsteroidal anti-inflammatory drugs for painkilling resolves in animals.

Thus, NSAIDs are leading the drug category as they are widely utilized in curing osteoarthritis-associated pain and irritation in animals. Furthermore, the key industry players are creating novel NSAIDs in order to reduce the side effects and reactions instigated by the prevailing ones.

In the coming few years, the joint pain category is projected to develop at the highest CAGR, of above 7.6%, mainly because of the growing count of pets, increasing quantity of overweight or obese pets, and rising occurrence of chronic illnesses, including osteoarthritis, in animals.

In the joint pain category, osteoarthritis held the highest revenue share, because of the mounting incidence of this condition, particularly in the dog family. NSAIDs and coxibs are given for mild-to-severe osteoarthritis aching, while nutraceuticals are desirable for moderate osteoarthritis pain. The most-used medicines for joint disorders such as Metacam, Rimadyl, Meloxicam, and Galliprant.

During the forecast period, the growing incidence of animal syndromes that cause pain and irritation is estimated to boost the development of the worldwide veterinary pain management industry. There are numerous inflammatory illnesses in pets, including cryptococcosis, canine distemper, coccidioidomycosis, rabies, neosporosis, and toxoplasmosis, also chronic illnesses, including chronic kidney disease cancer, and arthritis, most of which have pain as a warning sign.

In 2022, North America dominated the industry, with a market share of approximately 42%, and it is further projected to be on the leading spot, rising at a significant CAGR, in the coming few years.

This is mainly because of the rising occurrence of several infections, including those instigated by pests, which are resulting in the usage of animal antibiotics.

Other main boosters are the increasing ownership of friend animals, thriving knowledge regarding animal well-being, and the growing quantity of veterinary clinics in the continent.

Moreover, the existence of all main industry players in the continent will contribute to boosting the industry for veterinary pain management solutions.

Hence, the growing occurrence of musculoskeletal syndromes, including osteoarthritis, in animals, also the increasing acceptance of buddy and livestock animals, are the major factors propelling the veterinary pain management market.

17 maggio 2023

Empty Capsules Market Size, Growth, Development and Forecast Report 2030

In 2022, the global empty capsules market was worth around USD 2,818 million, and it is projected to advance at a 7.10% CAGR from 2022 to 2030, hitting USD 4,879 million by 2030, according to P&S Intelligence.

This growth can be credited to the rising acceptance of encapsulated medications among the elderly populace and the subsequent high demand for empty shells in the pharmaceutical, nutraceutical, and cosmeceutical industries.

Furthermore, the increasing number of research and development initiatives by companies and governments for novel medications and molecules, the growing count of medical trials, and forward-moving drug delivery technologies are boosting the industry.

Nutraceutical items, numerous of which are formed from whole grains, are typically rich in fiber, antioxidants, omega-3 fatty acids, vitamins and minerals, and heart-healthy ingredients. In recent years, the need for nutraceuticals has swiftly augmented because of the increasing occurrence of non-infectious illnesses, including diabetes, cancer, lung disorders, and heart ailments.

Moreover, the rising consumer knowledge regarding the health advantages of such items in disease avoidance and health augmentation is boosting their consumption. Henceforth, as the majority of nutraceuticals are retailed in the form of capsules, the demand for empty shells is increasing.

The key features boosting the empty capsules market are the increasing focus on pre-emptive care and the growing commercialization of gelatine-capsule-based medicine delivery arrangements. Thus, on the basis of type, in 2022, gelatin capsules held a higher revenue share, of above 82%, and this category is further projected to maintain its supremacy in the future as well.

In 2022, the immediate-release category generated a higher revenue share, and also the category is projected to be in the leading spot throughout the projection period. This can be credited to the fast-release form is extensively used for making painkillers, antacids, antibiotics, and several other types of medications, credited to its benefit of the fast onset of action.

This form offers an immediate breakdown of the capsules in the stomach, after incorporation. Decreasing the breakdown time advances the rate at which medications dissolve. Moreover, it is extensively utilized for making dietary supplements.

In 2022, with approximately 37%, market share North America dominated the empty capsules market, and is also projected to be dominant in the future as well. This can be credited to the presence of a substantial count of businesses with high-volume capsule manufacturing abilities and the utilization of this dosage form by a count of pharmaceutical titans.

Hence, the rising acceptance of encapsulated medications among the elderly populace and the subsequent high demand for empty shells in the pharmaceutical, nutraceutical, and cosmeceutical industries. Furthermore, the increasing number of research and development initiatives by companies and governments are the major factors propelling the empty capsules market.

16 maggio 2023

How Do Immunoassays Help in Drug Abuse Testing?

Testing for drugs of abuse (DOA) is a clinical screening method for identifying one or more unlawful substances, such as drugs, chemicals, or plant products. This clinical screening technique is carried out to determine whether any prescription or illicit medications are present in the patient’s saliva, urine, hair, blood, or perspiration.

P&S Intelligence says, by 2030, it is expected that the drug of abuse testing industry would be worth USD 10,485.7 million. The increase is due to a number of factors, including rising rates of technical development and increased public awareness of the negative consequences of drugs and alcohol.

Consumables account for the majority (over 60%), as they may be readily made accessible for drug testing on-site. The consumables only have a very short shelf life; therefore, they can only be used once before needing to be purchased again.

Additionally, immunoassay analyzers are frequently utilized because they offer a quick, affordable, and practical way to screen lots of samples in a range of matrices. The analyzers retain the second-largest share since they deliver accurate findings as well.

Since urine samples emit metabolites that can be easily examined for the existence of illicit substances and are unaffected by external factors, they dominate the market.

The majority of drugs may be detected in urine, which is another reason why it is preferred to collect urine collections for the testing of intoxicating substances. The non-invasive collection method, speedy results, and ability to identify the majority of drugs are other factors.

As a result, urinalysis-specific laboratories have significantly boosted their capacity thanks to the use of immunoassay analyzers and test kits. The usage of urine analysis for drugs has also increased as a result of technical developments in DOA testing techniques, the rising need for these procedures, and increase in overdose-related fatalities.

Due to the fact that hospitals perform the majority of DOA testing, hospitals account for 30% of all users. Additionally, a significant number of samples gathered elsewhere are submitted to hospitals for additional examination.

The dominance of hospitals in this market is attributable to their availability of sophisticated goods that can perform a variety of tests, as well as to their simple accessibility to drug screening devices and prescription medications.

The number of people wounded and killed in traffic accidents is counted, whether they occur right away or within 30 days of each other. Alcohol and other substances impair judgment, reflexes, motor function, impulse control, and decision-making, which increases the risk of traffic accidents and, frequently, fatalities.

The WHO estimates that 1.3 million people die in automobile accidents each year and that 20 million to 50 million people have non-fatal injuries.

The 2021 NSDUH found that 57.8% of adults 12 and older used cigarettes, alcohol, and illegal substances in 2021. Furthermore, 19.5% of them smoked, 14.3% used illegal substances, and 47.5% of them drank alcohol. Men are also more prone than women to use drugs and drink, as is common knowledge.

16 maggio 2023

North America Is Dominating Microfluidic Devices Industry

The total value of the global microfluidic devices market was USD 14,218.6 million in 2021, and it will rise at a growth rate of above 17.3% shortly, reaching USD 59,785.3 million by 2030, according to P&S Intelligence.

Microfluidics is a developing scientific area with an extensive variety of logical applications and commercial diagnoses in the arenas of cell biology research, protein crystallization, and medicine. Therefore, this technology is a vital tool to decrease side effects and advance the effectiveness of treatments.

Furthermore, the requirement for micromachined biological tools is projected to grow considerably in the coming few years, driven by the development of genomics and proteomics studies, and also the aimed incorporation of lab-on-a-chip tools into laboratory measures.

In Asia-Pacific, China is one of the fastest-rising industries for microfluidics because of the growing government backing and refining of healthcare amenities. Consequently, APAC is projected to arise as an appealing industry for businesses manufacturing like medicinal instruments.

Whereas, in Europe, the industry is boosted by the growing diagnosis needs, credited to the refining healthcare amenities and the increasing occurrence of illnesses; itself because of the lifestyle changes and elderly populace.

In 2021, the polymer category led the industry with a share of approximately 60%. the polymer has experienced a substantial surge in the application, specifically in the rapid prototyping of microfluidic devices, credited to the material’s comfort of fabrication into items and reduced price. Moreover, new surface alterations are being launched to resolve the difficulties brought on by the hydrophobicity of polymers.

Hence, the industry for microfluidic devices is boosted by their increasing utilization in genomic and proteomic research.

15 maggio 2023

North America Is Dominating Sleeping Aids Industry

The sleeping aids market is projected to be USD 157,484.5 million by 2030 growing at a CAGR of 7.3% during the forecast period, according to the estimates of the market research company, P&S Intelligence.

In 2021, North America held the largest revenue share approximately 50% in the market. This dominance can be credited to the rising frequency of sleep disorders and several initiatives by non-government and government organizations to spread awareness about the associated disorders and sleep hygiene.

In 2021, the size of the APAC sleeping aids market was $15 billion, and it is projected to grow at the highest rate in the years to come. Several sleeping disorders, like sleep apnea, sleepwalking, narcolepsy, insomnia, and restless leg syndrome need intervention, to avoid serious damage.

Majorly, the revenue in the industry is growing in APAC because of the high consumption of sleeping pills due to the changing lifestyle, long working hours, stress, and rising awareness about sleep disorders. Such reasons are growing the sales of sleeping aids.

The increasing acceptance of wearable monitoring devices and sensors is driving the market. Such devices support in transmission and record data related to several physiological conditions, for measuring and monitoring sleep quality. Some of the wearable sensors and monitors presented are BioHarness by BIOPAC Systems Inc., LifeVest by ZOLL Medical Corporation., LifeShirt by Aegis Limited, Zio XT by iRhythm Technologies Inc., and Sense Wear Armband by Jawbone.

Moreover, these devices are easy to use which makes them popular among people suffering from these disorders. Thus, with the increasing help from the usage of these instruments to monitor sleep quality, the requirement for sleeping aids is projected to grow.

In 2021, the Mattresses and pillows category had the highest revenue share, at approximately 40%. The availability of a wide range of international as well as local mattresses and pillows manufacturers makes these products cheaper which leads to their wide acceptance among people.

The Chinese market for products that support the sleep-deprived is rising at a high rate, mainly with youngsters looking to surge the quality and quantity of their sleep. Which indeed is contributing to the growth in the demand for obstructive sleep apnea machines, smart mattresses, and melatonin.

In China, with a growing amount of population suffering from sleep disorders, companies like Xilinmen and Xiaomi are spending more on scientific R&D to provide better products. Furthermore, key players are concentrating on exploring the potential effects of enhanced technology on sleep time.

Hence, the rising occurrence of obstructive sleep apnea, unhealthy routines of individuals, which is noticeable in the fluctuations in sleep and diet and patterns; and huge work pressure, are the major factors driving the sleeping aids market.

12 maggio 2023

North America Is Dominating Clinical Nutrition Industry

The clinical nutrition market size stood at USD 37.8 billion in 2021, which is expected to reach USD 70.8 billion by 2030, advancing at a CAGR of 7.2% during 2021–2030, as per P&S Intelligence.

This growth can be ascribed to the growing elderly population, a lift in the frequency of lifestyle-associated illnesses, a high birth rate and a high number of premature births, surging number of malnutrition sufferers, and athletes’ acceptance of sports nutrition items because of their several benefits.

The constant growth in the economic value of major operating businesses provides them with a competitive edge, for the innovation of new solutions. Additionally, corporations are constantly working to advance their current product line to maintain their dominating position. Therefore, corporations’ new growth strategies and foray into undeveloped regions to widen their reach are projected to drive the market.

The developing countries of LATAM, APAC, and MEA, including Brazil and India, are projected to contribute significantly to the market growth, as the major players are investing heavily in order to establish their footprint in such countries. The requirement for clinical nutrition in such countries is expanding with the rising geriatric and patient populations.

The cancer category is growing at a considerable rate in the clinical nutrition market, because of the growing cancer frequency globally. Products for enteral nutrition are considered an important solution for cancer treatment, as they avert nutritional deficiencies in the body, thus guaranteeing the proper functioning of many organs.

Cancer patients require a healthy diet because the illness might vary rate at which their bodies process nutrients and the degree to which this happens. Patients should get constant nutrient feedings as they are prone to becoming malnourished and losing weight.

North America, was responsible for the majority of clinical nutrition items sales, generating approximately 40% of the worldwide revenue, in 2021. The high frequency of cancer and disorders related to lifestyles involving a 9-to-5 desk job, a huge number of participants, and better reimbursement guidelines in comparison to other regions are some of the major reasons propelling the market growth.

Moreover, the well-developed healthcare infrastructure in the continent, high per capita income, and high healthcare investment are major factors contributing to the rising demand for clinical nutrition.

The APAC market is projected to witness the highest CAGR, of above 9%, in the coming years. This can be credited to the mounting geriatric population, snowballing birth rate, and high malnutrition rates in the region.

Hence, with the rising count of patients, booming geriatric population, and high count of prematurely born babies, the demand for clinical nutrition products continues to increase.

11 maggio 2023

Why do We Need Anti-Aging Treatments and Products in Modern Era?

An intricate biological process, skin aging is influenced by both external and internal factors. Women seem to favor anti-aging products the most. Mostly, women place a lot of position on having beautiful hair and skin.

Therefore, various anti-aging procedures and treatments have been introduced. People are increasingly more conscious about their appearance and health today.

Consumers are increasingly ready to spend money on these items for personal care due to the rising popularity of a variety of at-home gadgets for skin rejuvenation, cellulite reduction, wrinkle reduction, and microdermabrasion. These lightweight, convenient devices are also continually improved.

The use of at-home products is expanding internationally as individuals search for ways to retain their young appearance and the senior population concentrates on strategies to delay the onset of aging. The anti-aging market is predicted to touch $422,804.6 million by 2030.

Moreover, numerous conferences, exhibits, and conferences are being held all over the world to inform the public, plastic surgeons, and students about developments in anti-aging therapies. Therefore, a lot of players are actively participating in these exhibits and events to increase awareness of their goods.

People are becoming increasingly aware of the many issues related to aging skin, including fine lines, dullness, wrinkles, decreasing plumpness, and smoothness, in both emerging and established nations.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=anti-aging-market

In addition, the accessibility of cost-effective goods and solutions, increasing middle-aged consumer buying power, increasing personal disposable income, and growing standards of living are some of the other reasons that are significantly influencing the requirement for these products.

Retail establishments, drug shops, and internet retailers all serve as important distribution channels for growing sales. Among them, the internet category has been expanding quickly because of consumers’ growing preferences, ease of shopping, and increased after-sales services.

As a result, businesses and brands are diligently attempting to sell their inventory both online and offline to increase sales income.

Furthermore, hormonal changes brought on by delivery, pregnancy, menopause, and thyroid issues; genetic makeup that changes with age; side effects of numerous drugs & treatments; radiation exposure during treatment or other illnesses; a stressful lifestyle that promotes hair thinning; and excessive reliance on chemical sprays for hairstyling are some of the key reasons of hair loss.

In addition, problems with sleep, digestion, worry, and sadness inhibit hair development. Thus, this increases the demand for hair restoration procedures all over the world.

The elasticity and tightness of skin can be improved with the use of technologically enhanced products and techniques. They aid in the efficient treatment of wrinkles, fine lines, cellulite, and sunspots to improve skin firmness.

The efficacy and non-invasiveness of such items and methods are major advantages. These benefits have significantly enhanced the popularity of such solutions for use in hospitals and clinics as well as at home.

Additionally, the expansion of the business is being aided by the rising number of surgical and non-surgical operations being carried out in the area. For instance, the most common surgical treatments carried out in European nations include liposuction, breast augmentation, rhinoplasty, eyelid surgery, and abdominoplasty, whilst derma filler, Botox, and chemical peel are common non-surgical procedures.

10 maggio 2023

Boom Predicted in North American Dermatology Drugs Industry in Future

The global dermatology drugs market attained a value of $25,228.2 million in 2019 and is predicted to generate a revenue of $55,425.0 million by 2030.

According to the estimates of P&S Intelligence, a market research company based in India, the market would progress at a CAGR of 8.8% between 2020 and 2030. The surging geriatric population, the rising prevalence of skin diseases, and the soaring disposable income of people are the main factors driving the progress of the market.

The growing incidence of skin diseases in various countries is the biggest factor propelling the expansion of the dermatology drugs market across the world. Genetic and environmental factors, trauma, and aging are the main factors responsible for skin ailments. As per the World Health Organization (WHO), nearly 900 million people all over the world suffer from skin diseases at any particular time. Furthermore, skin problems are among the most-prevalent human health diseases across the world.

In the U.S., acne is the most prevalent skin disease and affects as many as 50 million Americans every year. As per the National Eczema Association, in the U.S., 31.6 million people were diagnosed with eczema in 2019. Due to the high prevalence of these diseases, the sales of dermatology drugs are growing rapidly across the globe. Besides this factor, the increasing public awareness of skin diseases is also positively impacting the growth of the dermatology drugs market.

Numerous medical product organizations are initiating programs for raising awareness about skin ailments. For example, Kisaco Research conducted Microbiome Connect Skin USA, which is a virtual summit, in June 2020 for recognizing the value of various skin-microbiome-based items as the next step in a person’s skincare regimen. Depending on prescription mode, the market is classified into over-the-counter (OTC) drugs and prescription drugs. Between these, the prescription drugs category recorded higher growth in the market in the past.

This was because of the availability of several prescription drugs, the high public preference for consultations with dermatologists, particularly for chronic skin ailments, and the high public awareness about skin problems. When end user is taken into consideration, the dermatology drugs market is classified into clinics, hospitals, cosmetic centers, and at-home settings. Out of these, the cosmetic centers category is predicted to register the fastest growth in the market in the future years.

This would be because of the rising focus of people all over the world on their appearance, the increasing number of cosmetic centers, and highly affordable beauty services provided in these facilities. Globally, the dermatology drugs market is predicted to exhibit the highest growth in North America in the upcoming years, on account of the growing public awareness of skin ailments and their skincare regiment and the existence of several established industry players in the regional countries.

Thus, it is quite clear that due to the growing prevalence of skin diseases and the increasing public awareness about the treatment of these diseases, the market would register huge expansion across the globe in the coming years.

9 maggio 2023

Wide Application of Cleanroom Consumables in Pharmaceutical Industry

The cleanroom consumables are utilized for maintaining cleanliness in a controlled environment. It ensures efficient and safe operations.

The cleanroom consumables industry has garnered $9,462.25 million revenue in 2021, and it is projected to generate $14,957.72 million, rising at a rate of 5.22% from 2021 to 2030. The growing demand for electric gadgets fuels the sales of consumables in the healthcare industry.

Moreover, the advancements in the changing consumer lifestyles boost the packaged food products demand with longer shelf life and sterility that provide better convenience.

The increasing R&D activities for developing vaccines against COVID-19 have encouraged pharmaceutical and biopharmaceutical businesses to massively invest in the development of a contamination-free environment.

Furthermore, cleanroom consumables are utilized in various industries, such as pharmaceutical, biotechnology, nanotechnology, and electronics industries. Buyers are aware of the importance of cleanroom consumables. It results in the growing demand for such products.

The massive availability of raw materials such as cellulose, rubber, polymers, and alcohol reduce the bargaining strength.

Gloves: These are automatically engineered so that they can fit on anyone’s fingers and are worn over the hands during working in the cleanroom. Such wearables offer comfort, strength, durability, flexibility, and appreciable electrostatic discharge performance. Surgical gloves are required for performing numerous surgeries and other medical procedures for maintaining hygiene.

Apparel: It is usually made non-shedding and lint-free, and worn in a controlled atmosphere. The manufacturing of such apparel complies with stringent regulations, to avoid the usage of several materials in their manufacturing, to prevent contaminant transmission between the cleanroom and wearer.

Wiper: A wiper is utilized inside the cleanroom for removing surface pollutants from the working area. They come in numerous sizes, materials, and textures that meet the user’s requirements. These are made of materials, such as polypropylene, cellulose, polyester, nylon, and cotton.

Adhesive mats: These are dust and dirt absorption pads that can be utilized at the entrance and walkways. These are made of several polyethylene sheets positioned on top of each other with the application of adhesive between the layers. The uppermost layers are removed after usage to reveal the fresh layer composed of adhesive.

Moreover, cleaning products are utilized in such facilities, as they are made of specialty materials for removing pollutants, including dirt, stains, dust, and chemical spills from the clean rooms. The majorly utilized cleaning products are buckets, mops, squeezes, wringers, validation swabs, and cleaning chemicals.

The major companies operating in the industry are:

1- Valutek Inc.

2- Contec Inc.

3- KM ACT CORP.

4- Texwipe

5- Berkshire Corporation

6- DuPont de Nemours Inc.

7- Kimberly-Clark Corporation

8- Micronova Manufacturing Inc.

9- Valutek Inc.

Therefore, the importance of cleanliness and sanitation to prevent infections, pollutants, and environmental contamination boosts demand for cleanroom consumables.